Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Texts to ease dementia caregiver stress after ER visits

NCT ID NCT07423871

Symptom relief Sponsor: Yale University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests a new text messaging program called CAPTURE for caregivers of people with dementia after an emergency department visit. The program sends up to two tailored texts per day for 30 days, covering topics like symptom monitoring, caregiver well-being, and community resources. Researchers will enroll 80 caregivers to see if the program is feasible, usable, and acceptable.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
text messaging support program
What this could lead to
If successful, this could provide a simple, low-cost way to support dementia caregivers after emergency visits, reducing stress and improving care.
What could go wrong
This is a small pilot study testing feasibility, not effectiveness. The program may not work for all caregivers or may not reduce burden significantly.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 80 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Mar 2027

An estimate. Start dates often move.

Expected to finish

Jun 2030

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Care partners (family members or close contacts) of persons living with cognitive impairment (PLWCI) who were evaluated and discharged from the emergency department (ED) * Age 18 years or older * Able to read and understand English or Spanish * Owns a mobile phone capable of receiving SMS text messages * Provides informed consent to participate in the study * Care recipient (PLWCI) resides in a community setting (i.e., not in a long-term care facility) Exclusion Criteria: * Care partner of a patient who is admitted to the hospital from the ED or transferred to a facility (e.g., skilled nursing facility) * Care partner who is already enrolled in another caregiving support trial or intervention study * Care partner who does not have regular access to a mobile phone with SMS capabilities * Care partner who is unable or unwilling to participate in follow-up over 30 days * Care partner of a patient enrolled in hospice or receiving end-of-life care

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Caregiver are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

dementia Emergencies

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Caregiver Dementia Emergency department Mobile health technology (mhealth)

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Yale New Haven Hospital Emergency Departments

    New Haven, Connecticut, 06520, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.